Breaking News Instant updates and real-time market news.

DAR

Darling Ingredients

$19.95

-0.03 (-0.15%)

, ADM

Archer Daniels

$41.73

-0.07 (-0.17%)

09:20
07/12/19
07/12
09:20
07/12/19
09:20

Darling Ingredients named a Fresh Pick at Baird

Baird analyst Ben Kallo named Darling Ingredients (DAR) as a Fresh Pick as he believes a rally in fat pricing should be a tailwind for the balance of the year. While he is more positive on Darling (DAR), Kallo said weather, trade, and African swine fever combine to make challenging ag environment more broadly and he is cautious in the near-term on Archer Daniels (ADM), Bunge (BG) and FMC Corporation (FMC). He keeps Outperform ratings on Darling and Archer and Neutral ratings on Bunge and FMC.

DAR

Darling Ingredients

$19.95

-0.03 (-0.15%)

ADM

Archer Daniels

$41.73

-0.07 (-0.17%)

BG

Bunge

$56.60

-0.585 (-1.02%)

FMC

FMC Corporation

$82.72

1.19 (1.46%)

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 08

    Aug

  • 20

    Aug

  • 21

    Aug

  • 13

    Nov

DAR Darling Ingredients
$19.95

-0.03 (-0.15%)

08/10/18
BARD
08/10/18
NO CHANGE
Target $24
BARD
Outperform
Baird still sees significant upside for Darling Ingredients
Baird analyst Ben Kallo believes the strategic alignment in the Food segment and other initiatives will position Darling Ingredients for long-term growth. The analyst said he remains a buyer and continues to see significant upside to current share prices. Kallo reiterated his Outperform rating and $24 price target on Darling Ingredient shares.
11/19/18
JPMS
11/19/18
UPGRADE
Target $25
JPMS
Overweight
JPMorgan sees earnings inflection for Darling, upgrades to Overweight
JPMorgan analyst Thomas Palmer upgraded Darling Ingredients to Overweight from Neutral and raised his price target for the shares to $25 from $21. The analyst continues to view the company's Diamond Green Diesel joint venture as the key driver of the stock. With the recently expanded joint venture facility now running at full capacity and Low Carbon Fuel Standards credits trading at "historically favorable levels," Darling's earnings should "inflect positively" starting in Q4 of 2018, Palmer tells investors in a research note. The analyst also thinks it is increasingly likely that the Blenders Tax Credit is approved for 2018 and 2019, which he estimates could provide nearly $1.50 per share to Darling. He sees a favorable near-term earnings setup for the stock.
11/19/18
JPMS
11/19/18
UPGRADE
Target $25
JPMS
Overweight
Darling Ingredients upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Thomas Palmer upgraded Darling Ingredients to Overweight and raised his price target for the shares to $25 from $21.
ADM Archer Daniels
$41.73

-0.07 (-0.17%)

04/30/19
STFL
04/30/19
NO CHANGE
Target $56
STFL
Buy
African Swine Fever can provide boost to Archer Daniels, says Stifel
Stifel analyst Vincent Anderson noted that the USDA's most recent estimates are for an 18% decline in pig herds in 2019 due to African Swine Fever. He said the African Swine Fever outbreak is likely to drive a widening in soybean crush margins, explaining that the net effect of increasing ex-China demand for protein will be to increase soybean meal demand and decrease soybean demand. This expected widening of crush margins provides upside for Archer Daniels, which can also benefit from increased demand for its edible bean and pea non-animal proteins, said Anderson, who keeps a Buy rating and $56 price target on Archer Daniels shares.
04/29/19
MSCO
04/29/19
NO CHANGE
Target $47
MSCO
Equal Weight
Archer ethanol spin would be smart, but not 'game changer,' says Morgan Stanley
Morgan Stanley analyst Vincent Andrews said he expects a mixed response to Archer Daniels' results and outlook, stating that the disappointing headline results were largely due to challenging weather conditions that should be looked through. The company also announced further restructuring steps and a plan to break out its ethanol business, and potentially spin it off, which Andrews sees as a smart thing to do, but doesn't envision being "a game changer" for the stock. The company also plans to cut capex by 10%, which he thinks is "very sensible" given Andrews thinks returns on growth capex haven't ultimately been obvious as attractive. He maintains an Equal Weight rating on Archer Daniels shares with a $47 price target.
04/29/19
BARD
04/29/19
NO CHANGE
Target $48
BARD
Outperform
Archer Daniels price target lowered to $48 from $54 at Baird
Baird analyst Ben Kallo maintained an Outperform rating on Archer Daniels but lowered his price target to $48 from $54 following the Q1 earnings miss, saying a potential China trade deal remains the central focus, which he thinks he is key driver of earnings in the second half and that any resolution would be a positive catalyst. The analyst sees sequential improvement in Q2 and likes the set-up headed into a potential earnings inflection in the second half of the year.
04/29/19
BMOC
04/29/19
UPGRADE
Target $51
BMOC
Outperform
Archer Daniels upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Kenneth Zaslow upgraded Archer Daniels to Outperform and raised his price target to $51 from $50 given the company's earnings inflection expected to come in the middle of 2019 and into 2020. The analyst cites Archer Daniels' "improvement in operations, potential catalysts such as U.S.-China trade resolution and global hog / chicken expansion." While the company missed on Q1 earnings on Friday, Zaslow believes that its "underlying fundamental recovery coupled with internal actions should create an acceleration of earnings power over the next several years."
BG Bunge
$56.60

-0.585 (-1.02%)

01/23/19
FBCO
01/23/19
NO CHANGE
Target $70
FBCO
Outperform
Bunge price target lowered to $70 from $77 at Credit Suisse
Credit Suisse analyst Robert Moskow lowered his price target for Bunge to $70 from $77 following management's EBIT guidance reduction for its Agribusiness and Sugar segment. The analyst reiterates an Outperform rating on the shares due to his view that Bunge's newly constituted board will generate shareholder value by slimming down the portfolio, improving execution, and possibly selling the business.
02/22/19
BMOC
02/22/19
NO CHANGE
Target $72
BMOC
Outperform
Bunge price target lowered to $72 from $83 at BMO Capital
BMO Capital analyst Kenneth Zaslow lowered his price target on Bunge to $72 after its Q4 earnings miss driven by a higher tax rate and expectations of flat FY19 EPS because of lower Agribusiness profits. The analyst also keeps his Outperform rating, saying investment in the stock may be "ripe" because of the appointment of new management, "severe earnings rebase", potential asset sales, cost savings opportunities, and limited downside given its current price relative to $48-$49 per share book value.
09/25/18
SBSH
09/25/18
NO CHANGE
SBSH
Buy
Citi sees 'significant turnaround' for Bunge, adds to Catalyst Watch list
Citi analyst David Driscoll added Bunge to its Catalyst Watch list ahead of the company's Q3 results. After meeting with CEO Soren Schroder, the analyst believes Bunge is set up for an inflection in Q3. He thinks the company can see "record" earnings in the second half of the year and a "significant turnaround" relative to its poor first half results. Driscoll keeps a Buy rating on the shares.
11/01/18
SBSH
11/01/18
NO CHANGE
Target $82
SBSH
Buy
Citi says Bunge is for sale, sees takeout value at $90 per share
Citi analyst David Driscoll says that with Bunge adding three "new, high quality" members to its board and initiating a strategic review, he believes the company is for sale in whole, or parts. The analyst thinks Bunge possesses medium term earnings power of $7.00 per share, and sees a takeout value of $90 per share. Driscoll lowered his price target for the stock to $82 from $92 and keeps a Buy rating on Bunge.
FMC FMC Corporation
$82.72

1.19 (1.46%)

06/13/19
SBSH
06/13/19
INITIATION
Target $93
SBSH
Buy
FMC Corporation assumed with a Buy at Citi
Citi analyst P.J. Juvekar assumed coverage of FMC Corporation with a Buy rating and $93 price target. The analyst says that despite current planting headwinds facing the Agriculture industry, FMC's "industry-leading" organic growth, diversification, and free cash flow improvement initiatives keeps him bullish.
05/20/19
05/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Canada Goose (GOOS) initiated with a Buy at HSBC. 2. OneSpaWorld (OSW) initiated with a Buy at Jefferies. 3. Zoom Video (ZM) initiated with an Outperform at William Blair. 4. Beyond Meat (BYND) initiated with an Equal Weight at Consumer Edge. 5. FMC Corporation (FMC) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/20/19
MSCO
05/20/19
INITIATION
Target $82
MSCO
Equal Weight
Morgan Stanley starts FMC Corporation at Equal Weight given patent worries
As previously reported, Morgan Stanley initiated FMC Corporation with an Equal Weight and $82 price target. Though analyst Vincent Andrews said he sees FMC as "the best growth story in Ag," he thinks the stock could be held back by investor concern over "real and perceived" challenges associated with managing patent expirations for products representing 35% of company sales in 2022+. While he notes that FMC's products have multiple patents that expire in different years in different key countries and he believes the patent expiration is largely manageable, Andrews recognizes that patent concerns could weigh on the stock in the interim.
05/20/19
MSCO
05/20/19
INITIATION
Target $82
MSCO
Equal Weight
FMC Corporation initiated with an Equal Weight at Morgan Stanley
Morgan Stanley initiated FMC Corporation with an Equal Weight and $82 price target.

TODAY'S FREE FLY STORIES

GDDY

GoDaddy

$73.63

0.58 (0.79%)

17:05
07/16/19
07/16
17:05
07/16/19
17:05
Hot Stocks
GoDaddy Chief Accounting Officer Rebecca Morrow resigns »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 14

    Aug

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:05
07/16/19
07/16
17:05
07/16/19
17:05
Hot Stocks
Breaking Hot Stocks news story on Nu Skin »

Nu Skin falls over 14% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:05
07/16/19
07/16
17:05
07/16/19
17:05
Earnings
Nu Skin cuts FY19 EPS view to $3.20-$3.35 from $3.80-$4.05, consensus $3.95 »

Cuts FY19 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:03
07/16/19
07/16
17:03
07/16/19
17:03
Earnings
Nu Skin cuts Q2 EPS view to 82c-84c from 91c-98c, consensus 94c »

Cuts Q2 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, ATVI

Activision Blizzard

$46.98

-0.67 (-1.41%)

16:58
07/16/19
07/16
16:58
07/16/19
16:58
Periodicals
Drake's esports team raises $35M, NY Post says »

According to a story from…

TCEHY

Tencent

$0.00

(0.00%)

ATVI

Activision Blizzard

$46.98

-0.67 (-1.41%)

NTES

NetEase

$259.36

3.01 (1.17%)

EA

Electronic Arts

$89.57

-2.65 (-2.87%)

NVDA

Nvidia

$167.06

-0.18 (-0.11%)

AMD

AMD

$33.82

-0.57 (-1.66%)

MSFT

Microsoft

$137.08

-1.86 (-1.34%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$117.49

0.47 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 19

    Jul

  • 30

    Jul

  • 30

    Jul

  • 05

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 15

    Aug

  • 05

    Sep

  • 13

    Nov

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

16:57
07/16/19
07/16
16:57
07/16/19
16:57
Downgrade
Cardiovascular Systems rating change  »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

UAL

United Continental

$94.00

2.7 (2.96%)

16:54
07/16/19
07/16
16:54
07/16/19
16:54
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

UAL

United Continental

$94.00

2.7 (2.96%)

16:53
07/16/19
07/16
16:53
07/16/19
16:53
Hot Stocks
United Continental sees Q3 total mainline aircraft of 804 »

Sees Q3 total regional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

UAL

United Continental

$94.00

2.7 (2.96%)

16:50
07/16/19
07/16
16:50
07/16/19
16:50
Hot Stocks
United Continental sees FY19 consolidated capacity growth 3%-4% y/y »

Sees FY19: Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

FARO

Faro Technologies

$46.95

-1.27 (-2.63%)

16:47
07/16/19
07/16
16:47
07/16/19
16:47
Hot Stocks
FARO names Allen Muhich CFO »

FARO announced that Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$38.70

0.28 (0.73%)

16:47
07/16/19
07/16
16:47
07/16/19
16:47
Earnings
Hancock Whitney reports Q2 EPS $1.01, consensus $1.00 »

Reports Q2 NII $219.9M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 23

    Sep

UAL

United Continental

$94.00

2.7 (2.96%)

16:44
07/16/19
07/16
16:44
07/16/19
16:44
Hot Stocks
United Continental sees Q3 capacity growth 2%-3% y/y »

Sees Q3: Adjusted pre-tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

16:39
07/16/19
07/16
16:39
07/16/19
16:39
General news
API crude inventories for week of July 12 »

API reports that crude…

HOPE

Hope Bancorp

$13.96

0.2 (1.45%)

16:37
07/16/19
07/16
16:37
07/16/19
16:37
Earnings
Hope Bancorp reports Q2 EPS 34c, consensus 34c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

INO

Inovio

$3.00

0.05 (1.69%)

16:35
07/16/19
07/16
16:35
07/16/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Inovio 

Inovio trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$4.27

1.43 (50.35%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
Syndicate
Immuron files to sell American Depositary Shares, no amount given »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$115.10

1.23 (1.08%)

, GS

Goldman Sachs

$215.57

4.02 (1.90%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The major averages were…

JPM

JPMorgan

$115.10

1.23 (1.08%)

GS

Goldman Sachs

$215.57

4.02 (1.90%)

JNJ

Johnson & Johnson

$132.46

-2.21 (-1.64%)

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

ARW

Arrow Electronics

$67.67

-1.15 (-1.67%)

TSLA

Tesla

$252.38

-1.03 (-0.41%)

APRN

Blue Apron

$10.33

2.68 (35.03%)

BYND

Beyond Meat

$172.50

5.9 (3.54%)

JBHT

J.B. Hunt

$97.76

5.26 (5.69%)

QTT

Qutoutiao

$4.31

-0.22 (-4.86%)

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 18

    Jul

  • 24

    Jul

  • 29

    Jul

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 26

    Aug

  • 09

    Sep

  • 16

    Sep

  • 12

    Oct

  • 13

    Nov

PBYI

Puma Biotechnology

$10.78

-0.42 (-3.75%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
Hot Stocks
Knight says Health Canada approves NERLYNX for early-stage breast cancer »

Knight Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.31

0.11 (0.68%)

16:31
07/16/19
07/16
16:31
07/16/19
16:31
Earnings
Fulton Financial reports Q2 EPS 35c, consensus 34c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

  • 07

    Aug

  • 03

    Sep

  • 05

    Sep

WAIR

Wesco Aircraft

$10.84

0.085 (0.79%)

16:30
07/16/19
07/16
16:30
07/16/19
16:30
Hot Stocks
Wesco Aircraft expans business with GKN Aerospace »

Wesco Aircraft Holdings,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
07/16/19
07/16
16:30
07/16/19
16:30
Options
Preliminary option volume of 17.5M today »

Preliminary option volume…

UBNK

United Financial

$14.07

0.05 (0.36%)

16:27
07/16/19
07/16
16:27
07/16/19
16:27
Earnings
United Financial reports Q2 EPS (6c), consensus 24c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

ERYP

Erytech Pharma

$6.69

(0.00%)

16:24
07/16/19
07/16
16:24
07/16/19
16:24
Syndicate
Erytech Pharma files to sell $100M of ADSs »

Representing ordinary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$79.57

1.05 (1.34%)

16:23
07/16/19
07/16
16:23
07/16/19
16:23
Earnings
CSX sees FY19 revenue down 1%-2% vs. prior view of growth »

CSX sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

INAP

Internap

$3.56

0.13 (3.79%)

16:22
07/16/19
07/16
16:22
07/16/19
16:22
Hot Stocks
Internap to streamline organization, initiates search for new CFO »

Internap announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.